v3.26.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES        
Net loss $ (11,473) $ (5,197) $ (10,549) $ (11,017)
Adjustments to reconcile net income (loss) to net cash flows used in operating activities:        
Stock-based compensation 567 362 615 961
Depreciation 21 25 53 58
Common stock issued for legal and other services 2,471 433 533
Loss on Conversion of Debt 367    
Interest related to Convertible Promissory Notes and Loan Facility     1,247 1,506
Changes in operating assets and liabilities:        
Accounts receivable (52) 615 639 770
Prepaid expenses and other current assets (206) 187 105 (303)
Accounts payable 5 (164) (110) (729)
Deferred revenue 74 17 (214) 497
Accrued and other current liabilities (112) 727 759 100
Net cash flows used in operating activities (8,338) (2,995) (6,922) (8,157)
CASH FLOWS FROM INVESTING ACTIVITIES        
Purchases and sell of property and equipment (27) (8) (34) (62)
Net cash flows used in by investing activities (27) (8) (34) (62)
CASH FLOWS FROM FINANCING ACTIVITIES        
Proceeds from related party loans     451 1,195
Payments as part of related party loans (596) (319) (1,605) (910)
Issuance of Series B-1 Preferred Stock     3,000
Issuance of Series CF-1 Preferred Stock 2,798 2,799 4,352
Issuance of Series CF-1 Preferred Stock fundraising fees (46) (46) (97)
Issuance of Series CF-2 Preferred Stock     819
Issuance of Series CF-2 Preferred Stock fundraising fees     (57)
Issuance of Series C preferred stock 3,000 3,000
Issuance of Series C preferred stock fundraising fees (254) (254)
Issuance of Series D convertible preferred stock 2,950 2,050
Issuance of Series D convertible preferred stock - issuance costs (272) (126)
Issuance of Promissory Note 4,000
Payment of Promissory Note (500)
Issuance of Common Stock under Equity Line of Credit 4,153    
Issuance of Common Stock under Equity Line of Credit - issuance costs (125)    
Exercise of Series C Common Warrants 3,356
Exercise of Series C Common Warrants - issuance costs (235)  
Exercise of Series D Common Warrants 1,879
Exercise of Series D Common Warrants - issuance costs (131)
Exercise of Common Stock Warrants 20
Direct Listing Costs (250)
Redemption of Series G convertible preferred stock (1,220)    
Cash dividends paid     (88)
Net cash flows provided by financing activities 13,029 5,179 6,943 7,540
Effect of exchange rate on cash (73) (57) (114) (32)
Change in cash, cash equivalents and restricted cash 4,591 2,119 (127) (711)
Cash, cash equivalents, and restricted cash beginning of period 599 726 726 1,437
Cash, cash equivalents, and restricted cash end of period 5,190 2,845 599 726
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:        
Cash paid for income taxes, net 75 58 119 48
SUPPLEMENTAL DISCLOSURES OF NON-CASH FLOW INFORMATION:        
Conversion of Loan Facility to convertible E Preferred Stocks     6,828
Common Stock Dividend 85 $ 384
Accounts payable associated with equity financing and unpaid dividends 753    
Common stock issued in connection with a direct listing 13,801    
Conversion of Preferred Stock into Common Stock 9,333    
Conversion of Convertible Notes into convertible preferred stock 3,302    
Debt Repayment with Stock $ 253